CD4 c.1318_1319delinsTA ;(p.S440Y)

Variant ID: 12-6928052-AG-TA

NM_000616.4(CD4):c.1318_1319delinsTA;(p.S440Y)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Development of Effective Siglec-9 Antibodies Against Cancer.

Current Oncology Reports
Wang, Jun Hui Shawn JHS; Jiang, Nan N; Jain, Amit A; Lim, Jackwee J
Publication Date: 2022-11-29

Variant appearance in text: CD4: S440Y
PubMed Link: 36445569
Variant Present in the following documents:
  • 11912_2022_Article_1347.pdf
View BVdb publication page



An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.

Nature Cancer
Chan, Sarah S; Belmar, Nicole N; Ho, Sun S; Rogers, Bryan B; Stickler, Marcia M; Graham, Michelle M; Lee, Eileen E; Tran, Ninian N; Zhang, Dong D; Gupta, Priyanka P; Sho, Mien M; MacDonough, Tracy T; Woolley, Andrew A; Kim, Han H; Zhang, Hong H; Liu, Wei W; Zheng, Pingping P; Dezso, Zoltan Z; Halliwill, Kyle K; Ceccarelli, Michele M; Rhodes, Susan S; Thakur, Archana A; Forsyth, Charles M CM; Xiong, Mengli M; Tan, Siu Sze SS; Iyer, Ramesh R; Lake, Marc M; Digiammarino, Enrico E; Zhou, Li L; Bigelow, Lance L; Longenecker, Kenton K; Judge, Russell A RA; Liu, Cassie C; Trumble, Max M; Remis, Jonathan P JP; Fox, Melvin M; Cairns, Belinda B; Akamatsu, Yoshiko Y; Hollenbaugh, Diane D; Harding, Fiona F; Alvarez, Hamsell M HM
Publication Date: 2022-03

Variant appearance in text: CD4: S440Y
PubMed Link: 35256819
Variant Present in the following documents:
  • 43018_2022_Article_334.pdf
View BVdb publication page



Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy.

Biotechnology And Bioprocess Engineering : Bbe
Kang, Seung Hyun SH; Lee, Chang-Han CH
Publication Date: 2021

Variant appearance in text: CD4: S440Y
PubMed Link: 34220207
Variant Present in the following documents:
  • 12257_2020_Article_181.pdf
View BVdb publication page



Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody.

The Journal Of Biological Chemistry
Zhang, Di D; Goldberg, Monica V MV; Chiu, Mark L ML
Publication Date: 2016-12-30

Variant appearance in text: CD4: S440Y
PubMed Link: 27856634
Variant Present in the following documents:
  • zbc27134.pdf
View BVdb publication page